19 November 2018

Amedeo Smart

Independent Medical Education

Subscriber: th..@boehringer-ingelheim.com

HIV Infection

19 November 2018 | n=35

  1. Chimukangara B, Kharsany AB, Lessells RJ, Naidoo K, et al.
    Moderate to high levels of pre-treatment HIV drug resistance in KwaZulu-Natal Province, South Africa.
    AIDS Res Hum Retroviruses 2018.

  2. Vasylyeva TI, Liulchuk M, du Plessis L, Fearnhill E, et al.
    The changing epidemiological profile of HIV-1 subtype B epidemic in Ukraine.
    AIDS Res Hum Retroviruses 2018.

  3. van Duin D, Gu P, Dong J, Pfaff M, et al.
    China-United States Research Collaborations in Antimicrobial Resistance.
    Clin Infect Dis 2018;67:S142-S145.

  4. Norris AH, Shrestha NK, Allison GM, Keller SC, et al.
    2018 IDSA Clinical Practice Guideline for the Management of Outpatient Parenteral Antimicrobial Therapy.
    Clin Infect Dis 2018.

  5. Crew PE, Abara WE, McCulley L, Waldron PE, et al.
    Disseminated gonococcal infections in patients receiving eculizumab: a case series.
    Clin Infect Dis 2018.

  6. Mutsaerts EAML, Nunes MC, van Rijswijk MN, Klipstein-Grobusch K, et al.
    Measles immunity at 4.5 years of age following vaccination at 9 and 15-18 months of age among HIV-infected, HIV-exposed-uninfected and HIV-unexposed children.
    Clin Infect Dis 2018.

  7. Hoenigl M, Moser C, Funderburg N, Bosch R, et al.
    Soluble Urokinase Plasminogen Activator Receptor (suPAR) is predictive of Non-AIDS Events during Antiretroviral Therapy-mediated Viral Suppression.
    Clin Infect Dis 2018.

  8. Clarke MA, Cheung LC, Lorey T, Hare B, et al.
    Five-year prospective evaluation of cytology, HPV testing, and biomarkers for detection of anal precancer in HIV+ MSM.
    Clin Infect Dis 2018.

  9. Rubin R.
    Have Tent, Will Do Pop-up HIV Screening.
    JAMA 2018.

  10. Rentsch CT, Tate JP, Steel T, Butt AA, et al.
    Medical intensive care unit admission among patients with and without HIV, hepatitis C virus, and alcohol-related diagnoses in the United States: a national, retrospective cohort study, 1997-2014.
    J Acquir Immune Defic Syndr 2018.

  11. Costagliola D, Potard V, Lang S, Abgrall S, et al.
    Impact of antiretroviral drugs on fracture risk in HIV-infected individuals: A case-control study nested within the French Hospital Database on HIV (FHDH-ANRS CO4).
    J Acquir Immune Defic Syndr 2018.

  12. Griffith D, Snyder J, Dell S, Nolan K, et al.
    Impact of a youth-focused care model on retention and virologic suppression among young adults with HIV cared for in an adult HIV clinic.
    J Acquir Immune Defic Syndr 2018.

  13. Blumenthal J, Jain S, Mulvihill E, Sun S, et al.
    Perceived versus calculated HIV risk: Implications for Pre-exposure prophylaxis uptake in a randomized trial of men who have sex with men.
    J Acquir Immune Defic Syndr 2018.

  14. Lewis L, Maughan-Brown B, Grobler A, Cawood C, et al.
    The impact of home-based HIV testing services on progress towards the UNAIDS 90-90-90 targets in a hyperendemic area of South Africa.
    J Acquir Immune Defic Syndr 2018.

  15. Billock RM, Powers KA, Pasquale DK, Samoff E, et al.
    Prediction OF HIV Transmission Cluster Growth with Statewide Surveillance Data.
    J Acquir Immune Defic Syndr 2018.

  16. Phillips TK, Wilson IB, Brittain K, Zerbe A, et al.
    Decreases in self-reported ART adherence predict HIV viremia among pregnant and postpartum South African women.
    J Acquir Immune Defic Syndr 2018.

  17. Jumare J, El-Kamary SS, Magder L, Hungerford L, et al.
    Body Mass Index and Cognitive Function among HIV-1 Infected Individuals in China, India and Nigeria.
    J Acquir Immune Defic Syndr 2018.

  18. Faini D, Kalinjuma AV, Katende A, Mbwaji G, et al.
    Laboratory-reflex cryptococcal antigen screening is associated with a survival benefit in Tanzania.
    J Acquir Immune Defic Syndr 2018.

  19. El Kamari V, Sattar A, McComsey GA.
    Gut structural damage, an ongoing process in chronically untreated HIV infection.
    J Acquir Immune Defic Syndr 2018.

  20. Colon K, Speicher DW, Smith P, Taylor M, et al.
    S100a14 is Increased in Activated Nk Cells and Plasma of HIV-Exposed Seronegative People Who Inject Drugs and Promotes Monocyte-Nk crosstalk.
    J Acquir Immune Defic Syndr 2018.

  21. Tortelli BA, Char DM, Crane JS, Powderly WG, et al.
    Comfort discussing HIV pre-exposure prophylaxis with patients among physicians in an urban emergency department.
    J Acquir Immune Defic Syndr 2018.

  22. Venter WDF, Kambugu A, Chersich MF, Becker S, et al.
    Efficacy and safety of tenofovir disoproxil fumarate versus low-dose stavudine over 96 weeks: a multi-country randomised, non-inferiority trial.
    J Acquir Immune Defic Syndr 2018.

  23. Arpadi S, Lamb M, Isaie Nzeyimana N, Vandebriel G, et al.
    Better outcomes among HIV-infected Rwandan children 18-60 months following the implementation of "treat all".
    J Acquir Immune Defic Syndr 2018.

  24. Weld ED, Rana MS, Dallas RH, Camacho-Gonzalez AF, et al.
    Interest of Youth Living with HIV in Long-Acting Antiretrovirals.
    J Acquir Immune Defic Syndr 2018.

  25. Verboeket SO, Wit FW, Kirk GD, Drummond MB, et al.
    Reduced Forced Vital Capacity among HIV-infected middle-aged individuals.
    J Infect Dis 2018.

  26. Malagnino V, Bottero J, Miailhes P, Lascoux-Combe C, et al.
    Hepatitis B virus genotype G and liver fibrosis progression in chronic hepatitis B and human immunodeficiency virus coinfection.
    J Med Virol 2018.

  27. Castillo-Menendez LR, Nguyen HT, Sodroski J.
    Conformational Differences Between Functional Human Immunodeficiency Virus (HIV-1) Envelope Glycoprotein Trimers and Stabilized Soluble Trimers.
    J Virol 2018.

  28. Anand SP, Prevost J, Baril S, Richard J, et al.
    Two families of Env antibodies efficiently engage Fc-gamma receptors and eliminate HIV-1-infected cells.
    J Virol 2018.

  29. Asbach B, Kibler KV, Kostler J, Perdiguero B, et al.
    Priming with a potent HIV-1 DNA vaccine frames the quality of immune responses prior to a poxvirus and protein boost.
    J Virol 2018.

  30. Kibler KV, Asbach B, Perdiguero B, Garcia-Arriaza J, et al.
    Replication-competent NYVAC-KC yields improved immunogenicity to HIV-1 antigens in rhesus macaques, compared to non-replicating NYVAC.
    J Virol 2018.

  31. Kumar S, Panda H, Makhdoomi MA, Mishra N, et al.
    An HIV-1 broadly neutralizing antibody from a clade C infected pediatric elite neutralizer potently neutralizes the contemporaneous and autologous evolving viruses.
    J Virol 2018.

  32. Cahn P, Madero JS, Arribas JR, Antinori A, et al.
    Dolutegravir plus lamivudine versus dolutegravir plus tenofovir disoproxil fumarate and emtricitabine in antiretroviral-naive adults with HIV-1 infection (GEMINI-1 and GEMINI-2): week 48 results from two multicentre, double-blind, randomised, non-infe
    Lancet 2018.

  33. Imperial MZ, Nahid P, Phillips PPJ, Davies GR, et al.
    Publisher Correction: A patient-level pooled analysis of treatment-shortening regimens for drug-susceptible pulmonary tuberculosis.
    Nat Med 2018.

  34. Meintjes G, Stek C, Blumenthal L, Thienemann F, et al.
    Prednisone for the Prevention of Paradoxical Tuberculosis-Associated IRIS.
    N Engl J Med 2018;379:1915-1925.

  35. Jumare J, Datong P, Osawe S, Okolo F, et al.
    Compromised Growth among HIV Exposed Uninfected Compared to Unexposed Children in Nigeria.
    Pediatr Infect Dis J 2018.

Display articles in

Amedeo HIV Infection

Data Origin

You selected the following journals for your Amedeo HIV Infection newsletter:

AIDS, AIDS Res Hum Retroviruses, Ann Intern Med, BMJ, Clin Infect Dis, J Acquir Immune Defic Syndr, J Clin Immunol, J Clin Invest, J Infect Dis, J Med Virol, J Virol, JAMA, Lancet, N Engl J Med, Nat Med, Pediatr Infect Dis J, Science, Virology.

To modify the journal selection, please open your Newsletter Management Page. If you don't remember the URL, please submit the email address of your Amedeo subscription.

Your email:

Amedeo HIV Infection

Five-Week Literature

19 November 2018

12 November 2018

05 November 2018

29 October 2018

22 October 2018

19 November 2018

Multidisciplinary Journal Club

  1. Zerna C, Thomalla G, Campbell BCV, Rha JH, et al.
    Current practice and future directions in the diagnosis and acute treatment of ischaemic stroke.
    Lancet. 2018;392:1247-1256.

  2. Gupta A, Mackay J, Whitehouse A, Godec T, et al.
    Long-term mortality after blood pressure-lowering and lipid-lowering treatment in patients with hypertension in the Anglo-Scandinavian Cardiac Outcomes Trial (ASCOT) Legacy study: 16-year follow-up results of a randomised factorial trial.
    Lancet. 2018 Aug 24. pii: S0140-6736(18)31776.

  3. Kluger HM, Chiang V, Mahajan A, Zito CR, et al.
    Long-Term Survival of Patients With Melanoma With Active Brain Metastases Treated With Pembrolizumab on a Phase II Trial.
    J Clin Oncol. 2018 Nov 8:JCO1800204. doi: 10.1200/JCO.18.00204.

Every week, Amedeo's Multidisciplinary Journal Club (MJC) presents a selection of outstanding articles. Take a look beyond the horizon.

Free Medical Abstracts
Privacy Policy

© Amedeo 1997-2016